Francès C, el Rassi R, Laporte J L, Rybojad M, Papo T, Piette J C
Department of Internal Medicine, Hôpital de la Pitié, 83, boulevard de l'Hôpital, 75651 Paris, France.
Medicine (Baltimore). 2001 May;80(3):173-9. doi: 10.1097/00005792-200105000-00003.
Dermatologic manifestations of relapsing polychondritis (RP) have been relatively poorly studied compared to other manifestations. In this study we describe dermatologic manifestations in a large series of patients with RP and the corresponding pathologic findings. In this retrospective, single-center review of 200 patients diagnosed with RP according to Michet's criteria, we analyzed separately those suffering from associated diseases with potential dermatologic involvement or chronic dermatitis. Skin or mucosal biopsies taken from 59 patients were examined without knowledge of the clinical data. Among the 200 patients with RP, 73 had chronic dermatitis or associated diseases with potential dermatologic involvement, especially hematologic disorders (n = 24) and connective tissue diseases (n = 22). Among the other 127 patients, 45 (35.4%) had dermatologic manifestations: aphthosis (n = 21; oral in 14 and complex in 7), nodules on the limbs (n = 19), purpura (n = 13), papules (n = 10), sterile pustules (n = 9), superficial phlebitis (n = 8), livedo reticularis (n = 7), ulcerations on the limbs (n = 6), and distal necrosis (n = 4). Dermatologic manifestations were the presenting feature of RP in 15 cases (12%), and appeared concomitantly (n = 23) or not (n = 22) with attacks of chondritis. Histologic findings included vasculitis (n = 19, leukocytoclastic in 17 and lymphocytic in 2), neutrophil infiltrates (n = 6), thrombosis of skin vessels (n = 4), septal panniculitis (n = 3), and minor changes (n = 2). Patients with and without dermatologic manifestations did not differ with regard to male/female ratio; age at RP onset; frequency of auricular, nasal, or tracheobronchial chondritis; or frequency of rheumatologic, ocular, audiovestibular, renal, arterial, or venous involvement. The frequency of dermatologic manifestations (91% versus 35.4%; p < 0.0001), sex ratio (18 male/4 female versus 44 male/83 female, p < 0.0001), and age at first chondritis (63.3 +/- 14 yr versus 41.4 +/- 17 yr; p < 0.0002) were significantly higher in the 22 patients with myelodysplastic syndrome than in the 127 patients without any associated disease. In conclusion, although dermatologic manifestations occur frequently in patients with RP, especially in association with myelodysplasia, they are nonspecific and sometimes resemble those observed in Behçet disease or inflammatory bowel diseases. Their presence in the elderly warrants repeated blood cell counts to detect a smouldering myelodysplasia.
与复发性多软骨炎(RP)的其他表现相比,其皮肤表现的研究相对较少。在本研究中,我们描述了一大系列RP患者的皮肤表现及相应的病理结果。在这项对200例根据米歇特标准诊断为RP的患者进行的回顾性单中心研究中,我们分别分析了那些患有可能累及皮肤的相关疾病或慢性皮炎的患者。对59例患者的皮肤或黏膜活检标本进行了检查,检查时不知其临床资料。在200例RP患者中,73例患有慢性皮炎或可能累及皮肤的相关疾病,尤其是血液系统疾病(n = 24)和结缔组织病(n = 22)。在其他127例患者中,45例(35.4%)有皮肤表现:口疮(n = 21;14例为口腔口疮,7例为复合型口疮)、四肢结节(n = 19)、紫癜(n = 13)、丘疹(n = 10)、无菌脓疱(n = 9)、浅表静脉炎(n = 8)、网状青斑(n = 7)、四肢溃疡(n = 6)和远端坏死(n = 4)。皮肤表现为RP首发特征的有15例(12%),与软骨炎发作同时出现(n = 23)或不同时出现(n = 22)。组织学表现包括血管炎(n = 19,17例为白细胞破碎性血管炎,2例为淋巴细胞性血管炎)、中性粒细胞浸润(n = 6)、皮肤血管血栓形成(n = 4)、间隔性脂膜炎(n = 3)和轻微改变(n = 2)。有皮肤表现和无皮肤表现的患者在男女比例、RP发病年龄、耳、鼻或气管支气管软骨炎的发生率,或风湿、眼、听觉前庭、肾、动脉或静脉受累的发生率方面无差异。22例骨髓增生异常综合征患者的皮肤表现发生率(91%对35.4%;p < 0.0001)、性别比(18例男性/4例女性对44例男性/83例女性,p < 0.0001)和首次软骨炎发病年龄(63.3±14岁对41.4±17岁;p < 0.0002)显著高于127例无任何相关疾病的患者。总之,虽然皮肤表现在RP患者中经常出现,尤其是与骨髓增生异常相关时,但它们是非特异性的,有时类似于白塞病或炎症性肠病中观察到的表现。老年人出现这些表现时需要反复进行血细胞计数以检测潜在的骨髓增生异常。